MA29841B1 - Comprimes dispersibles contenant du deferasirox - Google Patents

Comprimes dispersibles contenant du deferasirox

Info

Publication number
MA29841B1
MA29841B1 MA30795A MA30795A MA29841B1 MA 29841 B1 MA29841 B1 MA 29841B1 MA 30795 A MA30795 A MA 30795A MA 30795 A MA30795 A MA 30795A MA 29841 B1 MA29841 B1 MA 29841B1
Authority
MA
Morocco
Prior art keywords
dispersible tablets
tablets containing
dispersible
tablet
deferasirox
Prior art date
Application number
MA30795A
Other languages
English (en)
Inventor
Florian Battung
Jean-Pierre Cassiere
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA29841B1 publication Critical patent/MA29841B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention se rapporte à un comprimé dispersible, qui contient : (a) un composé I représenté par la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci, présent en une quantité comprise entre 42 % et 65 % poids par rapport au poids total du comprimé ; et (b) au moins un excipient pharmaceutiquement acceptable convenant à la préparation de comprimés dispersibles. L'invention a également trait à un procédé de fabrication dudit comprimé dispersible.
MA30795A 2005-10-19 2008-03-31 Comprimes dispersibles contenant du deferasirox MA29841B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0553182 2005-10-19

Publications (1)

Publication Number Publication Date
MA29841B1 true MA29841B1 (fr) 2008-10-03

Family

ID=36616771

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30795A MA29841B1 (fr) 2005-10-19 2008-03-31 Comprimes dispersibles contenant du deferasirox

Country Status (17)

Country Link
US (1) US20080311194A1 (fr)
EP (1) EP1940360A1 (fr)
JP (1) JP2009512652A (fr)
KR (1) KR20080056225A (fr)
CN (1) CN101291655A (fr)
AU (1) AU2006303514B2 (fr)
BR (1) BRPI0617715A2 (fr)
CA (1) CA2625112A1 (fr)
EC (1) ECSP088379A (fr)
IL (1) IL190397A0 (fr)
MA (1) MA29841B1 (fr)
NO (1) NO20082265L (fr)
NZ (1) NZ567155A (fr)
RU (1) RU2008119410A (fr)
TN (1) TNSN08173A1 (fr)
WO (1) WO2007045445A1 (fr)
ZA (1) ZA200802670B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009067557A1 (fr) * 2007-11-19 2009-05-28 Teva Pharmaceutical Industries Ltd. Compositions pharmaceutiques de déférasirox
WO2010035282A1 (fr) * 2008-09-24 2010-04-01 Matrix Laboratories Limited Compositions pharmaceutiques comprenant du deferasirox
ES2543427T3 (es) 2010-07-08 2015-08-19 Ratiopharm Gmbh Forma farmacéutica oral de deferasirox
MX2013003522A (es) * 2010-10-01 2013-05-22 Cipla Ltd Composicion farmaceutica.
MX2015003729A (es) 2012-11-12 2015-06-15 Cipla Ltd Composiciones farmaceuticas de dosis fija que comprende deferasirox y deferiprona.
HRP20190173T1 (hr) 2013-03-08 2019-03-22 Novartis Ag Oralne formulacije deferasiroksa
US20160120847A1 (en) * 2013-05-10 2016-05-05 Cipla Limited Low Dose Pharmaceutical Composition
ES2734675T3 (es) 2014-05-20 2019-12-11 Sanovel Ilac Sanayi Ve Ticaret As Formulación de comprimido dispersable en agua que contiene deferasirox
EP2987482A1 (fr) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Composition pharmaceutique soluble et dispersible contenant du déférasirox
WO2016167729A1 (fr) 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Comprimés dispersibles contenant du déférasirox
EP3095443A1 (fr) * 2015-05-21 2016-11-23 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Composition pharmaceutique contenant du déférasirox
MA43271A (fr) 2015-06-17 2018-09-26 Dispersol Technologies Llc Formulations améliorées de déférasirox et leurs procédés de fabrication
WO2018007956A1 (fr) * 2016-07-05 2018-01-11 Jubilant Generics Limited Composition pharmaceutique à libération immédiate d'agents chélateurs du fer
EP3518904A1 (fr) 2016-09-30 2019-08-07 Synthon B.V. Composition pharmaceutique comprenant du deferasirox
WO2018208242A1 (fr) * 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation de comprimé de déférasirox pour composition de suspension orale présentant une capacité de traitement améliorée
WO2019043427A1 (fr) 2017-09-01 2019-03-07 Jordan Sweden Medical And Sterilization Company Formes posologiques à auto-dispersion rapide de déférasirox
WO2019108157A1 (fr) * 2017-11-28 2019-06-06 Biofarma Ilac Sanayi Ve Ticaret A.S. Formulation de comprimé entaillé sous une forme dispersible comprenant du déférasirox
TR201722910A2 (tr) 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari
WO2022240279A1 (fr) * 2021-05-10 2022-11-17 Garcia Perez Miguel Angel Comprimé dispersible contenant du déférasirox sous forme de dispersion solide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
MY129541A (en) * 1996-06-25 2007-04-30 Novartis Ag Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound

Also Published As

Publication number Publication date
NZ567155A (en) 2010-06-25
IL190397A0 (en) 2008-11-03
TNSN08173A1 (en) 2009-10-30
WO2007045445A1 (fr) 2007-04-26
KR20080056225A (ko) 2008-06-20
ECSP088379A (es) 2008-05-30
ZA200802670B (en) 2009-10-28
CA2625112A1 (fr) 2007-04-26
EP1940360A1 (fr) 2008-07-09
BRPI0617715A2 (pt) 2011-08-02
AU2006303514B2 (en) 2010-06-24
JP2009512652A (ja) 2009-03-26
US20080311194A1 (en) 2008-12-18
RU2008119410A (ru) 2009-11-27
NO20082265L (no) 2008-05-16
AU2006303514A1 (en) 2007-04-26
CN101291655A (zh) 2008-10-22

Similar Documents

Publication Publication Date Title
MA29841B1 (fr) Comprimes dispersibles contenant du deferasirox
TNSN07275A1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
MA33836B1 (fr) Compositions pharmaceutiques contenant des ligands des récepteurs sigma
MA30781B1 (fr) Inhibiteur de kinase
MA29772B1 (fr) Benzimidazoles substitues et procedes de preparation
MA28432B1 (fr) Antagonistes du recepteur de la chimiokine
MA31466B1 (fr) Derives de benzimidazole
TNSN08270A1 (fr) Dérivés pyrimidiques destinés à traiter une croissance cellulaire anormale
TW200621232A (en) Compounds for inflammation and immune-related uses
TNSN08359A1 (fr) Derives d'amines
NO20076554L (no) Pyrimidin- eller triazinkondenserte, bisykliske metalloproteaseinhibitorer
IL173269A0 (en) Compounds for inflammation and immune-related uses
MA27654A1 (fr) DERIVES HEXAHYDROPYRAZINO [1,2-a]-4,7-DIONE SUBSTITUES, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS
MD2447G2 (ro) Compoziţie farmaceutică, utilizarea ei şi metodă de tratare a cefaleei, migrenei, greţurilor şi vomei
MA30351B1 (fr) Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation
MA33539B1 (fr) Comprimé
AR078270A1 (es) Inhibidores de jak (quinasas janus)
MA30916B1 (fr) Nouveaux derives de benzamide en tant qu'antagonistes de bradykinine
AR022019A1 (es) Un compuesto de imidazol y las composiciones farmaceuticas que lo contienen
MA28269A1 (fr) Arylpyrazoles substitués servant d'agents parasiticides
MA31926B1 (fr) Procédé pour la préparation de 1-(2h)-isoquinoléinones 6-substituées
MA33563B1 (fr) 5-(3,4-dichloro-phényl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-éthoxy)-nicotinamide et ses sels utilisés comme agents augmentant le cholestérol hdl
TNSN07355A1 (fr) Derives d'aryl-1,4-pyrazine substitues
TNSN06370A1 (fr) Derives de pyrimidine pour le traitement d'une croissance cellulaire anormale
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4